{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:25:02Z","timestamp":1791919502852,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T00:00:00Z","timestamp":1667606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T00:00:00Z","timestamp":1667606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Centre of Science","award":["2021\/41\/N\/NZ5\/02772"],"award-info":[{"award-number":["2021\/41\/N\/NZ5\/02772"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Endometrial cancer (EC) is one of the most common types of cancer of the female reproductive system. EC is classified into two types (EC1 and EC2). MiRNAs are single-stranded RNA molecules that regulate gene expression posttranscriptionally. They have aberrant expression profiles in cancer, including EC. This study aimed to assess the level of expression of a panel of 16 miRNAs in both types of EC and healthy endometrium (HE). A total of 45 patients were enrolled into the study, 18 patients diagnosed with EC1, 12 diagnosed with EC2, and 15 HE controls. Tumor tissues or healthy endometrial tissues were dissected from archival formalin-fixed paraffin-embedded (FFPE) using laser capture microdissection (LCM). RNA was isolated from collected material and the expression of selected miRNAs was determined using the real-time qPCR. We found that miR-23b, miR-125b-5p, miR-199a-3p, miR-221-3p, and miR-451a were downregulated in EC in comparison to HE. Moreover, the expression of miR-34a-5p and miR-146-5p was higher in EC1 compared to EC2. Analysis of The Cancer Genome Atlas (TCGA) database confirmed decreased levels of miR-23b, miR-125b-5p, and miR-199a-3p in EC. Decreased miR-23b expression was associated with worse survival of EC patients.<\/jats:p>","DOI":"10.1038\/s41598-022-22306-w","type":"journal-article","created":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T17:13:57Z","timestamp":1667668437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Decreased expression of miR-23b is associated with poor survival of endometrial cancer patients"],"prefix":"10.1038","volume":"12","author":[{"given":"Klaudia","family":"Klicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz M.","family":"Grzywa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Klinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Mielniczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Wejman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Ostrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Gondek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142 K.","family":"W\u0142odarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,5]]},"reference":[{"key":"22306_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41572-021-00324-8","volume":"7","author":"V Makker","year":"2021","unstructured":"Makker, V. et al. Endometrial cancer. Nat. Rev. Dis. Primers 7, 88. https:\/\/doi.org\/10.1038\/s41572-021-00324-8 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"22306_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 72, 7\u201333. https:\/\/doi.org\/10.3322\/caac.21708 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"22306_CR3","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle, E. E., Rodriguez, C., Walker-Thurmond, K. & Thun, M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348, 1625\u20131638. https:\/\/doi.org\/10.1056\/NEJMoa021423 (2003).","journal-title":"N. Engl. J. Med."},{"key":"22306_CR4","unstructured":"National Cancer Institute Surveillance, Epidemiology, and End results program. Cancer Stat facts: Uterine Cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/corp.html (2021). Accessed 1 Aug 2021."},{"key":"22306_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","volume":"15","author":"JV Bokhman","year":"1983","unstructured":"Bokhman, J. V. Two pathogenetic types of endometrial carcinoma. Gynecol. Oncol. 15, 10\u201317. https:\/\/doi.org\/10.1016\/0090-8258(83)90111-7 (1983).","journal-title":"Gynecol. Oncol."},{"key":"22306_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.mpdhp.2021.09.003","volume":"27","author":"M Masood","year":"2021","unstructured":"Masood, M. & Singh, N. Endometrial carcinoma: Changes to classification (WHO 2020). Diagn. Histopathol. 27, 493\u2013499. https:\/\/doi.org\/10.1016\/j.mpdhp.2021.09.003 (2021).","journal-title":"Diagn. Histopathol."},{"key":"22306_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"C Kandoth","year":"2013","unstructured":"Kandoth, C. et al. Integrated genomic characterization of endometrial carcinoma. Nature 497, 67\u201373. https:\/\/doi.org\/10.1038\/nature12113 (2013).","journal-title":"Nature"},{"key":"22306_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0034-1397344","volume":"35","author":"AM Mohr","year":"2015","unstructured":"Mohr, A. M. & Mott, J. L. Overview of microRNA biology. Semin. Liver Dis. 35, 3\u201311. https:\/\/doi.org\/10.1055\/s-0034-1397344 (2015).","journal-title":"Semin. Liver Dis."},{"key":"22306_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051723","author":"Z Ali Syeda","year":"2020","unstructured":"Ali Syeda, Z., Langden, S. S. S., Munkhzul, C., Lee, M. & Song, S. J. Regulatory mechanism of microRNA expression in cancer. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21051723 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"22306_CR10","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","volume":"1","author":"Y Peng","year":"2016","unstructured":"Peng, Y. & Croce, C. M. The role of MicroRNAs in human cancer. Signal Transduct. Target. Ther. 1, 15004. https:\/\/doi.org\/10.1038\/sigtrans.2015.4 (2016).","journal-title":"Signal Transduct. Target. Ther."},{"key":"22306_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","volume":"20","author":"LFR Gebert","year":"2019","unstructured":"Gebert, L. F. R. & MacRae, I. J. Regulation of microRNA function in animals. Nat. Rev. Mol. Cell Biol. 20, 21\u201337. https:\/\/doi.org\/10.1038\/s41580-018-0045-7 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"22306_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123709","author":"TM Grzywa","year":"2020","unstructured":"Grzywa, T. M., Klicka, K. & W\u0142odarski, P. K. Regulators at every step-how microRNAs drive tumor cell invasiveness and metastasis. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers12123709 (2020).","journal-title":"Cancers (Basel)"},{"key":"22306_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.Cd-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: New dimensions. Cancer Discov. 12, 31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-1059 (2022).","journal-title":"Cancer Discov."},{"key":"22306_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.canlet.2009.04.031","volume":"285","author":"K Ruan","year":"2009","unstructured":"Ruan, K., Fang, X. & Ouyang, G. MicroRNAs: Novel regulators in the hallmarks of human cancer. Cancer Lett. 285, 116\u2013126. https:\/\/doi.org\/10.1016\/j.canlet.2009.04.031 (2009).","journal-title":"Cancer Lett."},{"key":"22306_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","volume":"302","author":"B Zhang","year":"2007","unstructured":"Zhang, B., Pan, X., Cobb, G. P. & Anderson, T. A. microRNAs as oncogenes and tumor suppressors. Dev. Biol. 302, 1\u201312. https:\/\/doi.org\/10.1016\/j.ydbio.2006.08.028 (2007).","journal-title":"Dev. Biol."},{"key":"22306_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143393","author":"K Klicka","year":"2021","unstructured":"Klicka, K., Grzywa, T. M., Klinke, A., Mielniczuk, A. & W\u0142odarski, P. K. The role of miRNAs in the regulation of endometrial cancer invasiveness and metastasis\u2014a systematic review. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers13143393 (2021).","journal-title":"Cancers (Basel)"},{"key":"22306_CR17","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.18632\/oncotarget.27601","volume":"11","author":"H Donkers","year":"2020","unstructured":"Donkers, H., Bekkers, R. & Galaal, K. Diagnostic value of microRNA panel in endometrial cancer: A systematic review. Oncotarget 11, 2010\u20132023. https:\/\/doi.org\/10.18632\/oncotarget.27601 (2020).","journal-title":"Oncotarget"},{"key":"22306_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s10147-013-0526-9","volume":"18","author":"K Banno","year":"2013","unstructured":"Banno, K. et al. MicroRNAs in endometrial cancer. Int. J. Clin. Oncol. 18, 186\u2013192. https:\/\/doi.org\/10.1007\/s10147-013-0526-9 (2013).","journal-title":"Int. J. Clin. Oncol."},{"key":"22306_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2174\/2211536604666150710094418","volume":"4","author":"EN Kontomanolis","year":"2015","unstructured":"Kontomanolis, E. N. & Koukourakis, M. I. MicroRNA: The potential regulator of endometrial carcinogenesis. Microrna 4, 18\u201325. https:\/\/doi.org\/10.2174\/2211536604666150710094418 (2015).","journal-title":"Microrna"},{"key":"22306_CR20","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1186\/s12885-018-5085-z","volume":"18","author":"AL Sarver","year":"2018","unstructured":"Sarver, A. L., Sarver, A. E., Yuan, C. & Subramanian, S. O. M. C. D. OncomiR cancer database. BMC Cancer 18, 1223. https:\/\/doi.org\/10.1186\/s12885-018-5085-z (2018).","journal-title":"BMC Cancer"},{"key":"22306_CR21","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.7717\/peerj-cs.67","volume":"2","author":"J Anaya","year":"2016","unstructured":"Anaya, J. OncoLnc: Linking TCGA survival data to mRNAs, miRNAs, and lncRNAs. PeerJ Comput. Sci. 2, e67 (2016).","journal-title":"PeerJ Comput. Sci."},{"key":"22306_CR22","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li, J. H., Liu, S., Zhou, H., Qu, L. H. & Yang, J. H. starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 42, D92\u2013D97. https:\/\/doi.org\/10.1093\/nar\/gkt1248 (2014).","journal-title":"Nucleic Acids Res."},{"key":"22306_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"22306_CR24","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"22306_CR25","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Ishiguro-Watanabe, M. & Tanabe, M. KEGG: Integrating viruses and cellular organisms. Nucleic Acids Res. 49, D545\u2013D551. https:\/\/doi.org\/10.1093\/nar\/gkaa970 (2021).","journal-title":"Nucleic Acids Res."},{"key":"22306_CR26","doi-asserted-by":"publisher","first-page":"642","DOI":"10.2174\/1386207322666190325122821","volume":"25","author":"U Zaheer","year":"2019","unstructured":"Zaheer, U. et al. Expression profile of MicroRNA: An emerging hallmark of cancer. Curr. Pharm. Des. 25, 642\u2013653. https:\/\/doi.org\/10.2174\/1386207322666190325122821 (2019).","journal-title":"Curr. Pharm. Des."},{"key":"22306_CR27","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834\u2013838. https:\/\/doi.org\/10.1038\/nature03702 (2005).","journal-title":"Nature"},{"key":"22306_CR28","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s40291-017-0285-9","volume":"21","author":"N Petrovic","year":"2017","unstructured":"Petrovic, N., Erg\u00fcn, S. & Isenovic, E. R. Levels of microRNA heterogeneity in cancer biology. Mol. Diagn. Ther. 21, 511\u2013523. https:\/\/doi.org\/10.1007\/s40291-017-0285-9 (2017).","journal-title":"Mol. Diagn. Ther."},{"key":"22306_CR29","doi-asserted-by":"publisher","first-page":"6473038","DOI":"10.1155\/2021\/6473038","volume":"2021","author":"YX Guo","year":"2021","unstructured":"Guo, Y. X. et al. The role of miR-23b in cancer and autoimmune disease. J. Oncol. 2021, 6473038. https:\/\/doi.org\/10.1155\/2021\/6473038 (2021).","journal-title":"J. Oncol."},{"key":"22306_CR30","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/mc.22599","volume":"56","author":"S Chen","year":"2017","unstructured":"Chen, S. et al. The role of metastasis-associated in colon cancer 1 (MACC1) in endometrial carcinoma tumorigenesis and progression. Mol. Carcinog. 56, 1361\u20131371. https:\/\/doi.org\/10.1002\/mc.22599 (2017).","journal-title":"Mol. Carcinog."},{"key":"22306_CR31","doi-asserted-by":"publisher","first-page":"566","DOI":"10.18632\/genesandcancer.144","volume":"8","author":"M Jayaraman","year":"2017","unstructured":"Jayaraman, M. et al. Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer. Genes Cancer 8, 566\u2013576. https:\/\/doi.org\/10.18632\/genesandcancer.144 (2017).","journal-title":"Genes Cancer"},{"key":"22306_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21176071","volume":"21","author":"L Kalinkova","year":"2020","unstructured":"Kalinkova, L. et al. Discriminating miRNA profiles between endometrioid well- and poorly-differentiated tumours and endometrioid and serous subtypes of endometrial cancers. Int. J. Mol. Sci. 21, 1. https:\/\/doi.org\/10.3390\/ijms21176071 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"22306_CR33","doi-asserted-by":"publisher","first-page":"Br149","DOI":"10.12659\/msm.882617","volume":"18","author":"C Shang","year":"2012","unstructured":"Shang, C., Lu, Y. M. & Meng, L. R. MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2. Med. Sci. Monit. 18, Br149-155. https:\/\/doi.org\/10.12659\/msm.882617 (2012).","journal-title":"Med. Sci. Monit."},{"key":"22306_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.32471\/exp-oncology.2312-8852.vol-42-no-4.15522","volume":"42","author":"LG Buchynska","year":"2020","unstructured":"Buchynska, L. G., Borykun, T. V., Iurchenko, N. P., Nespryadko, S. V. & Nesina, I. P. Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium. Exp. Oncol. 42, 289\u2013294. https:\/\/doi.org\/10.32471\/exp-oncology.2312-8852.vol-42-no-4.15522 (2020).","journal-title":"Exp. Oncol."},{"key":"22306_CR35","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1097\/IGC.0b013e31829ea779","volume":"23","author":"D Wu","year":"2013","unstructured":"Wu, D., Huang, H.-J., He, C.-N. & Wang, K.-Y. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR). Int. J. Gynecol. Cancer 23, 1191\u20131197. https:\/\/doi.org\/10.1097\/IGC.0b013e31829ea779 (2013).","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"656","key":"22306_CR36","doi-asserted-by":"publisher","first-page":"e651","DOI":"10.1016\/j.ajog.2010.02.051","volume":"202","author":"DE Cohn","year":"2010","unstructured":"Cohn, D. E. et al. Comprehensive miRNA profiling of surgically staged endometrial cancer. Am. J. Obstet. Gynecol. 202(656), e651-656.e658. https:\/\/doi.org\/10.1016\/j.ajog.2010.02.051 (2010).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"656","key":"22306_CR37","doi-asserted-by":"publisher","first-page":"e651","DOI":"10.1016\/j.ajog.2010.02.051","volume":"202","author":"DE Cohn","year":"2010","unstructured":"Cohn, D. E. et al. Comprehensive miRNA profiling of surgically staged endometrial cancer. Am J Obstet Gynecol 202(656), e651-658. https:\/\/doi.org\/10.1016\/j.ajog.2010.02.051 (2010).","journal-title":"Am J Obstet Gynecol"},{"key":"22306_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00056","author":"J Song","year":"2017","unstructured":"Song, J. et al. Potential value of miR-221\/222 as diagnostic, prognostic, and therapeutic biomarkers for diseases. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2017.00056 (2017).","journal-title":"Front. Immunol."},{"key":"22306_CR39","doi-asserted-by":"publisher","first-page":"11069","DOI":"10.2147\/OTT.S230963","volume":"12","author":"H Bai","year":"2019","unstructured":"Bai, H. & Wu, S. miR-451: A novel biomarker and potential therapeutic target for cancer. Onco Targets Ther. 12, 11069\u201311082. https:\/\/doi.org\/10.2147\/OTT.S230963 (2019).","journal-title":"Onco Targets Ther."},{"key":"22306_CR40","doi-asserted-by":"publisher","first-page":"40221","DOI":"10.18632\/oncotarget.9574","volume":"7","author":"S Notaro","year":"2016","unstructured":"Notaro, S. et al. Evaluating L1CAM expression in human endometrial cancer using qRT-PCR. Oncotarget 7, 40221\u201340232. https:\/\/doi.org\/10.18632\/oncotarget.9574 (2016).","journal-title":"Oncotarget"},{"key":"22306_CR41","doi-asserted-by":"publisher","first-page":"23253","DOI":"10.18632\/oncotarget.25298","volume":"9","author":"P Dong","year":"2018","unstructured":"Dong, P., Xiong, Y., Yue, J., Hanley, S. J. B. & Watari, H. miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation. Oncotarget 9, 23253\u201323263. https:\/\/doi.org\/10.18632\/oncotarget.25298 (2018).","journal-title":"Oncotarget"},{"key":"22306_CR42","doi-asserted-by":"publisher","first-page":"111258","DOI":"10.18632\/oncotarget.22770","volume":"8","author":"Z Wang","year":"2017","unstructured":"Wang, Z. et al. MicroRNA-34a inhibits cells proliferation and invasion by downregulating Notch1 in endometrial cancer. Oncotarget 8, 111258\u2013111270. https:\/\/doi.org\/10.18632\/oncotarget.22770 (2017).","journal-title":"Oncotarget"},{"key":"22306_CR43","doi-asserted-by":"publisher","first-page":"462","DOI":"10.18632\/oncotarget.1552","volume":"5","author":"U Schirmer","year":"2014","unstructured":"Schirmer, U. et al. Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma. Oncotarget 5, 462\u2013472. https:\/\/doi.org\/10.18632\/oncotarget.1552 (2014).","journal-title":"Oncotarget"},{"key":"22306_CR44","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1111\/andr.12780","volume":"8","author":"N Nakamura","year":"2020","unstructured":"Nakamura, N., Davis, K., Yan, J., Sloper, D. T. & Chen, T. Increased estrogen levels altered microRNA expression in prostate and plasma of rats dosed with sex hormones. Andrology 8, 1360\u20131374. https:\/\/doi.org\/10.1111\/andr.12780 (2020).","journal-title":"Andrology"},{"key":"22306_CR45","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.7150\/ijbs.47203","volume":"16","author":"B He","year":"2020","unstructured":"He, B. et al. miRNA-based biomarkers, therapies, and resistance in Cancer. Int. J. Biol. Sci. 16, 2628\u20132647. https:\/\/doi.org\/10.7150\/ijbs.47203 (2020).","journal-title":"Int. J. Biol. Sci."},{"key":"22306_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9061900","volume":"9","author":"E Coll-de la Rubia","year":"2020","unstructured":"Coll-de la Rubia, E. et al. Prognostic biomarkers in endometrial cancer: A systematic review and meta-analysis. J. Clin. Med. 9, 1. https:\/\/doi.org\/10.3390\/jcm9061900 (2020).","journal-title":"J. Clin. Med."},{"key":"22306_CR47","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1080\/0284186x.2018.1540886","volume":"58","author":"S Hutt","year":"2019","unstructured":"Hutt, S. et al. The role of biomarkers in endometrial cancer and hyperplasia: A literature review. Acta Oncol. (Stockholm, Sweden) 58, 342\u2013352. https:\/\/doi.org\/10.1080\/0284186x.2018.1540886 (2019).","journal-title":"Acta Oncol. (Stockholm, Sweden)"},{"key":"22306_CR48","doi-asserted-by":"publisher","first-page":"797","DOI":"10.14670\/hh-26.797","volume":"26","author":"R Klopfleisch","year":"2011","unstructured":"Klopfleisch, R., Weiss, A. T. & Gruber, A. D. Excavation of a buried treasure\u2013DNA, mRNA, miRNA and protein analysis in formalin fixed, paraffin embedded tissues. Histol. Histopathol. 26, 797\u2013810. https:\/\/doi.org\/10.14670\/hh-26.797 (2011).","journal-title":"Histol. Histopathol."},{"key":"22306_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083886","author":"TM Grzywa","year":"2021","unstructured":"Grzywa, T. M. et al. Higher mutation burden in high proliferation compartments of heterogeneous melanoma tumors. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22083886 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"22306_CR50","doi-asserted-by":"publisher","first-page":"e0234707","DOI":"10.1371\/journal.pone.0234707","volume":"15","author":"TM Grzywa","year":"2020","unstructured":"Grzywa, T. M. et al. miR-410-3p is induced by vemurafenib via ER stress and contributes to resistance to BRAF inhibitor in melanoma. PLoS ONE 15, e0234707. https:\/\/doi.org\/10.1371\/journal.pone.0234707 (2020).","journal-title":"PLoS ONE"},{"key":"22306_CR51","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00418-020-01941-2","volume":"155","author":"K Pe\u0142ka","year":"2021","unstructured":"Pe\u0142ka, K. et al. miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia-archival samples study. Histochem. Cell Biol. 155, 423\u2013433. https:\/\/doi.org\/10.1007\/s00418-020-01941-2 (2021).","journal-title":"Histochem. Cell Biol."},{"key":"22306_CR52","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s12020-019-01960-7","volume":"65","author":"TM Grzywa","year":"2019","unstructured":"Grzywa, T. M. et al. Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN\/AKT, and STAT3 signaling pathways. Endocrine 65, 646\u2013655. https:\/\/doi.org\/10.1007\/s12020-019-01960-7 (2019).","journal-title":"Endocrine"},{"key":"22306_CR53","doi-asserted-by":"publisher","first-page":"e92444","DOI":"10.1371\/journal.pone.0092444","volume":"9","author":"C Guzm\u00e1n","year":"2014","unstructured":"Guzm\u00e1n, C., Bagga, M., Kaur, A., Westermarck, J. & Abankwa, D. ColonyArea: An ImageJ plugin to automatically quantify colony formation in clonogenic assays. PLoS ONE 9, e92444. https:\/\/doi.org\/10.1371\/journal.pone.0092444 (2014).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22306-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22306-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22306-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T17:29:32Z","timestamp":1667669372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22306-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,5]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["22306"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-22306-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,5]]},"assertion":[{"value":"5 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18824"}}